|
SYAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.28466159721575E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.23649995692676E-11 |
| Normal-vs-Stage2 |
2.38149999720605E-09 |
| Normal-vs-Stage3 |
4.30877555857023E-13 |
| Normal-vs-Stage4 |
8.18270000000343E-05 |
| Stage1-vs-Stage2 |
4.214400E-01 |
| Stage1-vs-Stage3 |
4.037800E-02 |
| Stage1-vs-Stage4 |
7.714000E-01 |
| Stage2-vs-Stage3 |
4.669000E-01 |
| Stage2-vs-Stage4 |
7.621200E-01 |
| Stage3-vs-Stage4 |
3.749000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62012633811537E-14 |
| Normal-vs-AfricanAmerican |
3.58390000000375E-05 |
| Normal-vs-Asian |
9.428200E-01 |
| Caucasian-vs-AfricanAmerican |
6.943200E-01 |
| Caucasian-vs-Asian |
2.741000E-01 |
| AfricanAmerican-vs-Asian |
3.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.513700E-02 |
| Male-vs-Female |
4.38920011447408E-11 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.036100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.15449871884721E-11 |
| Normal-vs-Age(61-80Yrs) |
1.97697413995002E-12 |
| Normal-vs-Age(81-100Yrs) |
2.389600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.091800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.128600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.265600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.740600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.649200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.388600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.456300E-02 |
| Normal-vs-Grade 2 |
1.61659996500418E-09 |
| Normal-vs-Grade 3 |
5.88418203051333E-14 |
| Normal-vs-Grade 4 |
1.5412005005544E-11 |
| Grade 1-vs-Grade 2 |
4.711200E-01 |
| Grade 1-vs-Grade 3 |
1.553410E-01 |
| Grade 1-vs-Grade 4 |
7.204200E-02 |
| Grade 2-vs-Grade 3 |
4.622500E-02 |
| Grade 2-vs-Grade 4 |
5.561800E-02 |
| Grade 3-vs-Grade 4 |
8.721800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72850622703891E-12 |
| Normal-vs-ccB subtype |
6.77070000065783E-09 |
| ccA subtype-vs-ccB subtype |
3.891000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.88320478603055E-11 |
| Normal-vs-N1 |
6.88109999980036E-07 |
| N0-vs-N1 |
3.236400E-01 |
|
|
